Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MEASuRE: Metreleptin Effectiveness And Safety Registry

NCT02325674 is registered in ClinicalTrials.gov with Chiesi Farmaceutici S.p.A. as lead sponsor.

NCT NCT02325674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02325674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MEASuRE: Metreleptin Effectiveness And Safety Registry
Lead sponsor
Chiesi Farmaceutici S.p.A.
Phase
Observational
Overall status
Recruiting
Start date
October 11, 2016
Completion date
October 31, 2031
Enrollment
100 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

generalised lipodystrophy, partial lipodystrophy